Is Pfizer Inc. (PFE) the Best Dividend Stock With 5% Yield?

We recently compiled a list of the 12 Best 5% Dividend Stocks To Buy According To Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend stocks.

Dividend investors have often debated the balance between high yields and dividend growth. Analysts tend to favor companies with robust dividend growth, advising investors to avoid the yield traps. However, many studies suggest that high dividend yields aren’t necessarily a negative factor.

An example of this is a report from Newton Investment Management, which found that high-yield dividend stocks outperformed the broader market during periods of high inflation between 1940 and 2021. The report also showed that portfolios with high-yield dividend stocks performed better than those with low or no dividends, with high-yield portfolios exceeding low-yield ones by 199 basis points and zero-yield portfolios by 330 basis points. While the findings are insightful, the report lacks details on the specific market conditions during these periods, offering only a general overview of high-yield stock performance. Analysts have closely studied how dividend stocks fare during market volatility, given the heightened need for consistent income. As a result, they recommend considering high-yield stocks only if these companies also demonstrate a solid track record of dividend growth.

Also read: 10 Best Dividend Stocks Yielding at Least 7% According to Analysts

This is a common challenge for investors, who often believe that companies with strong dividend growth don’t offer high yields. However, this isn’t necessarily the case. Many companies provide above-average dividend yields while also maintaining solid records of dividend growth. In fact, dividend yield plays an important role in sustaining dividend growth. For example, the Dividend Aristocrats Index, which includes companies that have increased their dividends for 25 consecutive years, has managed to maintain a high yield without sacrificing growth. Over the 26 years ending in 2023, the index consistently outperformed its benchmark while maintaining yields between 2% and 2.9%. On average, the index yielded 2.5%, notably higher than the market average of 1.8%, as reported by S&P Dow Jones Indices.

Analysts typically recommend targeting dividend yields between 3% and 6%, as this range tends to offer the best balance of potential for both dividend growth and stock price appreciation. A report from Nuveen highlighted that global companies with moderate dividend yields (ranging from 0% to 3%) generally show stronger earnings growth, profitability, and profit margins compared to those with higher yields or no dividends at all. These factors also help reduce risk, particularly in times of market volatility.

Another study by Wellington Management highlighted the historical outperformance of high-yield stocks. The report analyzed dividend-paying stocks in the broader market index from 1930 to 2019 and grouped them into five categories based on their dividend yields. The top 20% of dividend payers performed the best, followed by the moderate dividend group, both surpassing the broader market in multiple periods. However, the lower dividend groups showed less consistent performance and generally underperformed the index. Given this, we will now take a look at some of the best dividend stocks with over 5% yield.

Our Methodology:

For this list, we scanned Insider Monkey’s database of 900 hedge funds as of the third quarter of 2024 and picked 12 dividend stocks that have yields above 5%, as of February 5. These companies have strong histories of paying dividends to shareholders. The stocks are ranked in ascending order of hedge funds’ sentiment toward them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

Is Pfizer Inc. (PFE) the Safe Stock to Buy for the Long Term in 2025?

A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution.

Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 80

Dividend Yield as of February 5: 6.5%

Pfizer Inc. (NYSE:PFE) is an American pharmaceutical company that mainly manufactures, markets, and sells related products worldwide. The company made significant strides in commercial execution and experienced growth across its product portfolio for the full year of 2024. This included $3.4 billion in revenue from its legacy Seagen portfolio, as well as strong growth from products such as Vyndaqel, Eliquis, Xtandi, Nurtec, and several others across various categories.

In addition, Pfizer Inc. (NYSE:PFE) reported 12% operational revenue growth from its non-COVID products for the full year of 2024, highlighting the continued focus on commercial execution. It successfully achieved its $4 billion net cost savings target from the ongoing cost realignment program. As reflected in its 2025 financial guidance, the company has increased its overall savings target to about $4.5 billion by the end of the year. In addition, it is on track to achieve $1.5 billion in net cost savings from the first phase of the Manufacturing Optimization Program by the end of 2027, with initial savings expected in the latter half of 2025. The company remains confident in its ability to return to pre-pandemic operating margins in the years ahead.

Pfizer Inc. (NYSE:PFE) currently offers a quarterly dividend of $0.43 per share, having raised it by 2.4% in December 2024. This marked the company’s 15th consecutive year of dividend growth, which makes PFE one of the best dividend stocks on our list. The stock supports a dividend yield of 6.5%, as of February 5.

As of Q3 2024, 80 hedge funds tracked by Insider Monkey held stakes in Pfizer Inc. (NYSE:PFE), down from 84 in the previous quarter. These stakes are collectively valued at over $3 billion. With nearly 17 million shares, Two Sigma Advisors was the company’s leading stakeholder in Q3.

Overall PFE ranks 1st on our list of the best dividend stocks with over 5% yield. While we acknowledge the potential for PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stock To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.